ACE and glomerulosclerosis: Other studies showed that aliskiren reduced albuminuria and glomerulosclerosis to a similar extent as the ACE inhibitor perindopril, despite lower BP reduction [85], and in non-diabetic mRen-2 rats, aliskiren and the ARB irbesartan similarly attenuated glomerular structural and functional changes[86].